You’ll fill out these digital forms inside the portal (for yourself, and any family members 18 or older): Generic Application Form for Canada (IMM 0008) Get the instructions (opens in a new tab) ...
Late-stage clinical biotechnology company developing Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback